查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1403403

到 2030 年防揭包装市场预测：按产品、材料、应用、最终用户和地区进行全球分析

Tamper Evident Packaging Market Forecasts to 2030 - Global Analysis By Product, Material, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球防揭包装市场规模为 17.8 亿美元，预计在预测期内将以 8.2% 的复合年增长率增长，到 2030 年达到 38.4 亿美元。

防揭包装透过提供可见的篡改和诈欺征兆来确保药品和医疗产品的完整性。它们在确保患者安全和维持药物有效性方面发挥关键作用。透过利用密封件、标籤和封口等旨在防止破损或在打开时显示篡改证据的功能，防防揭包装可以为消费者和医疗保健专业人员提供信心。

印度包装研究所(IIP)的数据显示，过去十年印度的包装消费量激增200%，从2010年的4.3公斤人均年消费量(pppa)增加到2020年的8.6公斤pppa。

成长动力：仿冒品增加

随着药品和医疗产品的假冒现像不断增加，防揭包装为消费者和医疗保健专业人员提供了重要的安全层，以确保产品的完整性。防篡改功能有助于防止在产品分发和储存过程中诈欺的存取和篡改，从而保护患者的健康和福祉。因此，医疗保健产业越来越多地采用防揭包装解决方案来应对日益增长的假药威胁。

成长抑制因素：相容性问题

药品种类繁多，需要适合其需求的包装解决方案。实现防揭功能与不同包装材料、尺寸和形状之间的兼容性是一项挑战。障碍在于平衡有效的诈欺篡改和适应不同的产品规格。这种复杂性增加了製造成本并阻碍了与现有药物製造流程的无缝整合。

机会：人们对产品安全的认知与兴趣不断增强

随着消费者对药品和医疗产品的真实性和完整性越来越警惕，防揭包装已成为一个重要的解决方案。透过提供干扰或篡改的明显证据，建立信任并确保消费者产品的完整性。这种对安全性的日益关注与医疗保健行业维持最高标准的承诺是一致的，而防揭包装满足并支持了对安全可靠的医疗保健产品不断增长的需求。这是一个值得利用的重要策略。

威胁：成本

实施防揭包装解决方案通常需要在材料、技术和遵守严格法规方面产生额外成本。对创新密封件、全像标籤和其他安全措施的需求增加了製造成本。医疗保健行业的预算普及可能会阻碍相关人员的采用并限制其获得防揭包装。此外，实施防篡改技术需要研发投资才能领先造假者，这进一步阻碍了市场扩张。

COVID-19 的影响

COVID-19 的疫情对市场产生了重大影响。人们对卫生和安全意识的提高增加了对药品和医疗包装中防篡改解决方案的需求，以确保产品的完整性。这场大流行加速了防揭包装的采用，以防止污染和诈欺的取得医疗用品。这导致了防篡改技术的投资和创新激增，重塑了医疗保健包装形势，以解决行业中日益增长的安全问题。

处方药市场预计将在预测期内成为最大的市场

处方药领域预计将出现良好的成长。透过采用各种密封件和特征，该包装确保了药品的完整性。透过提供篡改或篡改企图的明显证据，防揭包装使消费者和医疗保健专业人员对药品的真实性和安全性充满信心。这种预防措施有助于降低污染、替代和诈欺取得处方药的风险，加强监管合规性，并提高病患对药品供应链的信任。

预计製药领域在预测期内复合年增长率最高

预计製药公司细分市场在预测期内将以最高的复合年增长率成长。防揭包装在製药公司确保药品的安全性和完整性方面发挥着重要作用。这包括整合可揭示任何干扰并提供明显篡改证据的功能。这对于防止污染、伪造和诈欺获取药品至关重要。它还透过确保药品的真实性和安全性来保护消费者，并促进整体公共卫生和监管合规性。

比最大的地区

由于对假药和医疗产品的担忧日益增加，预计亚太地区在预测期内将占据最大的市场占有率。印度和中国等国家特别采用这些包装技术，以确保整个供应链中药品和医疗设备的完整性。 Amcor Limited、Mondi Group、DuPont 和 Sonoco 等主要公司都在印度开展业务。此外，严格的法规、对病人安全的日益关注以及医疗保健相关人员意识的提高，导致对防揭包装解决方案的需求不断增长。

复合年增长率最高的地区

由于严格的法规和对病人安全的日益重视，预计欧洲在预测期内将经历最高的复合年增长率。随着欧洲不断加强医疗保健标准，解决与产品安全和真实性相关的关键问题，该地区的防揭包装市场持续扩大。欧洲的主要企业包括 Essentra Plc、Clondalkin Group 和 Sappi Limited。主要企业正在利用先进技术进行创新，提供防篡改解决方案，将欧洲定位为市场的关键地区。

免费客製化服务：

订阅此报告的客户可以利用以下免费自订选项之一：

  • 公司简介
    • 其他市场公司的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 公司之间的竞争关係

第五章全球防揭包装市场：依产品

  • 收缩套管
  • 感应密封
  • 薄膜包装纸
  • 泡壳/带状包装
  • 气泡包
  • 其他产品

第六章全球防揭包装市场：依材料分类

  • 塑胶
  • 玻璃
  • 纸
  • 金属
  • 其他材料

第七章全球防揭包装市场：依应用分类

  • 成药(OTC)
  • 处方药
  • 生技药品
  • 医疗设备
  • 其他用途

第八章全球防揭包装市场：依最终用户分类

  • 製药公司
  • 医疗设备製造商
  • 医院和诊所
  • 研究机构
  • 其他最终用户

第九章全球防揭包装市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第10章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司简介

  • Schreiner Group
  • Avery Dennison Corporation
  • CCL Industries Inc
  • Essentra PLC
  • 3M Company
  • SCHOTT AG
  • Amcor Plc
  • DuPont de Nemours Inc
  • Systech International
  • Covectra
  • Ampac Holding LLC
  • Baker & McKenzie LLP
  • Dynacorp
  • Enercon Corporation
  • Berry Global Healthcare
  • Traco Manufacturing Inc
  • Interpack Limited
  • Seal King Europe
Product Code: SMRC24628

According to Stratistics MRC, the Global Tamper Evident Packaging Market is accounted for $1.78 billion in 2023 and is expected to reach $3.84 billion by 2030 growing at a CAGR of 8.2% during the forecast period. Tamper-evident packaging ensures the integrity of pharmaceuticals and medical products by providing visible signs of interference or tampering. It plays a critical role in safeguarding patient safety and maintaining the efficacy of medications. Utilizing features like seals, labels, and closures that are designed to break or show evidence of tampering upon opening, tamper-evident packaging instills confidence in consumers and healthcare professionals.

According to the Indian Institute of Packaging (IIP), packaging consumption in India has surged by 200% over the last decade, from 4.3 kilograms per person per annum (pppa) in FY10 to 8.6 kg pppa in FY20.

Market Dynamics:

Driver:

Rising incidents of counterfeiting

With the rise in counterfeit drugs and medical products, tamper-evident packaging provides a crucial layer of security, assuring consumers and healthcare professionals of the product's integrity. The tamper-resistant features help prevent unauthorized access and tampering during the product's distribution and storage, safeguarding the health and well-being of patients. As a result, the healthcare industry is increasingly embracing tamper-evident packaging solutions to combat the growing threat of counterfeit pharmaceuticals.

Restraint:

Compatibility issues

The diverse range of pharmaceutical products often requires tailored packaging solutions. Achieving compatibility between tamper-evident features and various packaging materials, sizes, and forms can be challenging. Striking a balance between effective tamper resistances and accommodating different product specifications becomes a hurdle. This complexity can result in increased production costs and hinder seamless integration into existing pharmaceutical manufacturing processes.

Opportunity:

Growing awareness & concern for product safety

As consumers become increasingly vigilant about the authenticity and integrity of pharmaceuticals and medical products, tamper-evident packaging serves as a crucial solution. It helps build trust by providing visible evidence of any interference or tampering, assuring consumers of product integrity. This heightened focus on safety aligns with the healthcare sector's commitment to maintaining the highest standards, making tamper-evident packaging a key strategy to address and capitalize on the increasing demand for secure and trustworthy healthcare products.

Threat:

Cost considerations

Implementing tamper-evident packaging solutions often involves additional expenses for materials, technology, and compliance with stringent regulations. The need for innovative seals, holographic labels, or other security measures increases production costs. The healthcare industry's budget constraints may deter widespread adoption, limiting access to tamper-proof packaging for some stakeholders. Additionally, implementing tamper-evident technologies requires investment in research and development to stay ahead of counterfeiters which further impedes the market expansion.

COVID-19 Impact

The COVID-19 pandemic has significantly impacted the market. With heightened awareness of hygiene and safety, there is an increased demand for tamper-evident solutions in pharmaceutical and medical packaging to ensure product integrity. The pandemic has accelerated the adoption of tamper-proof packaging to prevent contamination and unauthorized access to medical supplies. This has led to a surge in investments and innovations in tamper-evident technologies, reshaping the healthcare packaging landscape to meet the evolving safety concerns in the industry.

The prescription drugs segment is expected to be the largest during the forecast period

The prescription drugs segment is estimated to have a lucrative growth. Employing various seals and features, this packaging ensures the integrity of pharmaceutical products. By visibly indicating any interference or opening attempts, tamper-evident packaging provides consumers and healthcare professionals with confidence in the authenticity and safety of the medication. This preventive measure helps mitigate the risk of contamination, substitution, or unauthorized access to prescription drugs, reinforcing regulatory compliance and promoting patient trust in the pharmaceutical supply chain.

The pharmaceutical companies segment is expected to have the highest CAGR during the forecast period

The pharmaceutical companies segment is anticipated to witness the highest CAGR growth during the forecast period. Tamper-evident packaging plays a crucial role in pharmaceutical companies to ensure the safety and integrity of medical products. It involves incorporating features that reveal any interference, providing visible evidence of tampering. This is paramount for preventing contamination, counterfeiting, and unauthorized access to medications. It also protects consumers by guaranteeing the authenticity and safety of medications, promoting overall public health and regulatory compliance.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to the escalating concerns about counterfeit drugs and medical products. Countries like India and China are particularly embracing these packaging technologies to ensure the integrity of pharmaceuticals and medical devices throughout the supply chain. It has the presence of major companies namely Amcor Limited, Mondi Group, DuPont and Sonoco. Further, stringent regulations, a growing focus on patient safety, and increasing awareness among healthcare stakeholders contribute to the expanding demand for tamper-evident packaging solutions.

Region with highest CAGR:

Europe is projected to have the highest CAGR over the forecast period, owing to stringent regulations and the growing emphasis on patient safety. As Europe remains committed to enhancing healthcare standards, the Tamper-Evident Packaging market in the region continues to witness expansion, addressing critical concerns related to product safety and authenticity. Europe is home to several key players including Essentra Plc, Clondalkin Group and Sappi Limited. Key players are innovating with advanced technologies to offer tamper-proof solutions, positioning Europe as a pivotal region in the market.

Key players in the market:

Some of the key players profiled in the Tamper Evident Packaging Market include Schreiner Group, Avery Dennison Corporation, CCL Industries Inc, Essentra PLC, 3M Company, SCHOTT AG, Amcor Plc, DuPont de Nemours Inc, Systech International, Covectra, Ampac Holding LLC, Baker & McKenzie LLP, Dynacorp, Enercon Corporation, Berry Global Healthcare, Traco Manufacturing Inc, Interpack Limited and Seal King Europe.

Key Developments:

In April 2023, Schreiner MediPharm has launched a new product for counterfeit and tampering protection in the healthcare industry. The product utilizes void labels, which reveals covert messages upon peeling and makes it difficult for counterfeiters to reuse the original packaging.

In February 2023, Berry Global Healthcare is introducing a comprehensive bundle solution to help customers capitalise on the increasing demand for child-resistant (CRC) and tamper-evident (TE) packaging for the pharmaceutical and herbal market for syrup and liquid medicines. The new Berry Healthcare bundle features seven ranges of 28mm neck PET bottles in sizes from 20ml to 1,000ml and a variety of designs, with eight accompanying closures that incorporate tamper-evident and child-resistant features.

Products Covered:

  • Shrink Sleeves
  • Induction Seal
  • Film Wrappers
  • Blister/Strip Packs
  • Bubble Packs
  • Other Products

Materials Covered:

  • Plastic
  • Glass
  • Paper
  • Metal
  • Other Materials

Applications Covered:

  • Over-The-Counter (OTC) Drugs
  • Prescription Drugs
  • Biologics
  • Medical Devices
  • Other Applications

End Users Covered:

  • Pharmaceutical Companies
  • Medical Device Manufacturers
  • Hospitals & Clinics
  • Research Institutions
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Tamper Evident Packaging Market, By Product

  • 5.1 Introduction
  • 5.2 Shrink Sleeves
  • 5.3 Induction Seal
  • 5.4 Film Wrappers
  • 5.5 Blister/Strip Packs
  • 5.6 Bubble Packs
  • 5.7 Other Products

6 Global Tamper Evident Packaging Market, By Material

  • 6.1 Introduction
  • 6.2 Plastic
  • 6.3 Glass
  • 6.4 Paper
  • 6.5 Metal
  • 6.6 Other Materials

7 Global Tamper Evident Packaging Market, By Application

  • 7.1 Introduction
  • 7.2 Over-The-Counter (OTC) Drugs
  • 7.3 Prescription Drugs
  • 7.4 Biologics
  • 7.5 Medical Devices
  • 7.6 Other Applications

8 Global Tamper Evident Packaging Market, By End User

  • 8.1 Introduction
  • 8.2 Pharmaceutical Companies
  • 8.3 Medical Device Manufacturers
  • 8.4 Hospitals & Clinics
  • 8.5 Research Institutions
  • 8.6 Other End Users

9 Global Tamper Evident Packaging Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Schreiner Group
  • 11.2 Avery Dennison Corporation
  • 11.3 CCL Industries Inc
  • 11.4 Essentra PLC
  • 11.5 3M Company
  • 11.6 SCHOTT AG
  • 11.7 Amcor Plc
  • 11.8 DuPont de Nemours Inc
  • 11.9 Systech International
  • 11.10 Covectra
  • 11.11 Ampac Holding LLC
  • 11.12 Baker & McKenzie LLP
  • 11.13 Dynacorp
  • 11.14 Enercon Corporation
  • 11.15 Berry Global Healthcare
  • 11.16 Traco Manufacturing Inc
  • 11.17 Interpack Limited
  • 11.18 Seal King Europe

List of Tables

  • Table 1 Global Tamper Evident Packaging Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Tamper Evident Packaging Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Tamper Evident Packaging Market Outlook, By Shrink Sleeves (2021-2030) ($MN)
  • Table 4 Global Tamper Evident Packaging Market Outlook, By Induction Seal (2021-2030) ($MN)
  • Table 5 Global Tamper Evident Packaging Market Outlook, By Film Wrappers (2021-2030) ($MN)
  • Table 6 Global Tamper Evident Packaging Market Outlook, By Blister/Strip Packs (2021-2030) ($MN)
  • Table 7 Global Tamper Evident Packaging Market Outlook, By Bubble Packs (2021-2030) ($MN)
  • Table 8 Global Tamper Evident Packaging Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 9 Global Tamper Evident Packaging Market Outlook, By Material (2021-2030) ($MN)
  • Table 10 Global Tamper Evident Packaging Market Outlook, By Plastic (2021-2030) ($MN)
  • Table 11 Global Tamper Evident Packaging Market Outlook, By Glass (2021-2030) ($MN)
  • Table 12 Global Tamper Evident Packaging Market Outlook, By Paper (2021-2030) ($MN)
  • Table 13 Global Tamper Evident Packaging Market Outlook, By Metal (2021-2030) ($MN)
  • Table 14 Global Tamper Evident Packaging Market Outlook, By Other Materials (2021-2030) ($MN)
  • Table 15 Global Tamper Evident Packaging Market Outlook, By Application (2021-2030) ($MN)
  • Table 16 Global Tamper Evident Packaging Market Outlook, By Over-The-Counter (OTC) Drugs (2021-2030) ($MN)
  • Table 17 Global Tamper Evident Packaging Market Outlook, By Prescription Drugs (2021-2030) ($MN)
  • Table 18 Global Tamper Evident Packaging Market Outlook, By Biologics (2021-2030) ($MN)
  • Table 19 Global Tamper Evident Packaging Market Outlook, By Medical Devices (2021-2030) ($MN)
  • Table 20 Global Tamper Evident Packaging Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 21 Global Tamper Evident Packaging Market Outlook, By End User (2021-2030) ($MN)
  • Table 22 Global Tamper Evident Packaging Market Outlook, By Pharmaceutical Companies (2021-2030) ($MN)
  • Table 23 Global Tamper Evident Packaging Market Outlook, By Medical Device Manufacturers (2021-2030) ($MN)
  • Table 24 Global Tamper Evident Packaging Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
  • Table 25 Global Tamper Evident Packaging Market Outlook, By Research Institutions (2021-2030) ($MN)
  • Table 26 Global Tamper Evident Packaging Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.